ORGANIC
LETTERS
2013
Vol. 15, No. 4
856–859
Synthesis of Quinolones by
Nickel-Catalyzed Cycloaddition
via Elimination of Nitrile
Kenichiro Nakai, Takuya Kurahashi,* and Seijiro Matsubara*
Department of Material Chemistry, Graduate School of Engineering, Kyoto University,
Kyoto 615-8510, Japan, and JST, ACT-C, 4-1-8 Honcho, Kawaguchi, Saitama,
332-0012, Japan
kurahashi.takuya.2c@kyoto-u.ac.jp; matsubara.seijiro.2e@kyoto-u.ac.jp
Received December 26, 2012
ABSTRACT
Substituted quinolones were efficiently synthesized via the nickel-catalyzed cycloaddition of o-cyanophenylbenzamide derivatives with alkynes.
The reaction involves elimination of a nitrile group by cleavage of the two independent arylÀcyano and arylÀcarbonyl CÀC bonds of the amides.
A number of N-heterocycles containing carbonyl groups
have been recognized as biologically active agents,
quinolones1 and isoquinolones2 being among the most
representative examples of such heterocycles. Because of
their functionality, development of synthetic routes and
methods for the functionalization of these compounds is of
great significance.3 From this perspective, we have devel-
oped cycloaddition reactions of heterocycles with alkynes
to generate such benzopyridones via the elimination of
CO4a (Scheme 1, eq 1) or CO24b (eq 2). We further attempted
to synthesize 2-quinolone from o-cyanophenylbenzamides
and alkynes via the elimination of nitrile, using a nickel
catalyst (eq 3).5
The initial treatment of o-cyanophenylbenzamide deri-
vative 1a and 4-octyne 2a in the presence of a nickel catalyst
(prepared in situ from Ni(cod)2 and P(CH2Ph)3 using
methylaluminum bis(2,6-di-tert-butyl-4-methylphenoxide)
(MAD) as a cocatalyst by treatment in toluene at 120 °C for
12 h) generated quinolone 3aa in 36% yield (Table 1, entry 1).
(3) For selected examples of transition-metal-catalyzed syntheses
and functionalizations of 2-quinolone, see: (a) Kadnikov, D. V.; Larock,
R. C. J. Organomet. Chem. 2003, 687, 425. (b) Kadnikov, D. V.; Larock,
R. C. J. Org. Chem. 2004, 69, 6772. (c) Battistuzzi, G.; Bernini, R.;
Cacchi, S.; de Salve, I. Adv. Synth. Catal. 2007, 349, 297. (d) Queiroz, M.
J. R. P.; Abreu, A. S.; Calhelha, R. C.; Carvalho, M. S. D.; Ferreira,
P. M. T.; Fabrizi, G. Tetrahedron 2008, 64, 5139. (e) Tadd, A. C.;
Matsuno, A.; Fielding, M. R.; Willis, M. C. Org. Lett. 2009, 11, 583. (f)
Tang, D.-J.; Tang, B.-X.; Li, J.-H. J. Org. Chem. 2009, 74, 6749. (g)
Inamoto, K.; Saito, T.; Hiroya, K.; Doi, T. J. Org. Chem. 2010, 75, 3900.
(h) Iwai, T.; Fujihara, T.; Terao, J.; Tsuji, Y. J. Am. Chem. Soc. 2010,
132, 9602. (i) Fu, L.; Huang, X.; Wang, D.; Zhao, P.; Ding, K. Synthesis
2011, 1547. (j) Kato, H.; Ishigame, T.; Oshima, N.; Hoshiya, N.;
Shimawaki, K.; Arisawa, M.; Shuto, S. Adv. Synth. Catal. 2011, 353,
2676. (k) Tang, B.-X.; Song, R.-J.; Wu, C.-Y.; Wang, Z.-Q.; Liu, Y.;
Huang, X.-C.; Xiea, Y.-X.; Li, J.-H. Chem. Sci. 2011, 2, 2131. (l)
Borhade, S. R.; Waghmode, S. B. Can. J. Chem. 2011, 89, 1355.
(4) (a) Kajita, Y.; Kurahashi, T.; Matsubara, S. J. Am. Chem. Soc.
2008, 130, 6058. (b) Yoshino, Y.; Kurahashi, T.; Matsubara, S. J. Am.
Chem. Soc. 2009, 131, 7494.
(1) For selected examples, see: (a) Hamann, L. G.; Higuchi, R. I.; Zhi,
L.; Edwards, J. P.; Wang, X.-N.; Marschke, K. B.; Kong, J. W.; Farmer,
L. J.; Jones, T. K. J. Med. Chem. 1998, 41, 623. (b) Naito, Y.;
Yoshikawa, T.; Tanigawa, T.; Sakurai, K.; Yamasaki, K.; Uchida,
M.; Kondo, M. Free Radical Biol. Med. 1995, 18, 117. (c) Joseph, B.;
ꢀ
Darro, F.; Behard, A.; Lesur, B.; Collignon, F.; Decaestecker, C.;
Frydman, A.; Guillaumet, G.; Kiss, R. J. Med. Chem. 2002, 45, 2543.
(d) Kraus, J. M.; Verlinde, C. L. M. J.; Karimi, M.; Lepesheva, G. I.;
Gelb, M. H.; Buckner, F. S. J. Med. Chem. 2009, 52, 1639.
(2) For selected examples, see: (a) Krane, B. D.; Shamma, M. J. Nat.
Prod. 1982, 45, 377. (b) Calogero, A. E.; Kamilaris, T. C.; Bernardini, R.;
Johnson, E. O.; Chrousos, G. P.; Gold, P. W. J. Pharmacol. Exp. Ther.
1990, 253, 729. (c) Ikeura, Y.; Tanaka, T.; Kiyota, Y.; Morimoto, S.;
Ogino, M.; Ishimaru, T.; Kamo, I.; Doi, T.; Natsugari, H. Chem. Pharm.
Bull. 1997, 45, 1642. (d) Miura, T.; Yamauchi, M.; Murakami, M. Org.
Lett. 2008, 10, 3085. (e) Maezaki, H.; Banno, Y.; Miyamoto, Y.;
Moritou, Y.; Asakawa, T.; Kataoka, O.; Takeuchi, K.; Suzuki, N.;
Ikedo, K.; Kosaka, T.; Sasaki, M.; Tsubotani, S.; Tani, A.; Funami, M.;
Yamamoto, Y.; Tawada, M.; Aertgeerts, K.; Yano, J.; Oi, S. Bioorg.
Med. Chem. 2011, 19, 4482. (f) Du, J.; Xi, L.; Lei, B.; Liu, H.; Yao, X.
Chem. Biol. Drug Des. 2011, 77, 248.
(5) We recently reported a new method for generating coumarins from
o-arylcarboxybenzonitriles and alkynes via elimination of nitrile in the
presence of a nickel catalyst; see: Nakai, K.; Kurahashi, T.; Matsubara, S.
J. Am. Chem. Soc. 2011, 133, 11066.
r
10.1021/ol303546p
Published on Web 01/25/2013
2013 American Chemical Society